Remove Allergies Remove Nurses Remove Research Remove Vaccination
article thumbnail

Pfizer Responds to Research Claims

Pfizer

Pfizer Responds to Research Claims carterda Fri, 01/27/2023 - 19:48 Pfizer Responds to Research Claims Friday, January 27, 2023 - 08:00pm Share New York, N.Y., In the ongoing development of the Pfizer-BioNTech COVID-19 vaccine, Pfizer has not conducted gain of function or directed evolution research.

Research 112
article thumbnail

Lilly’s antibody for COVID-19 protection starts nursing home trial

pharmaphorum

While the world waits an effective coronavirus vaccine, Eli Lilly has started late-stage human testing an antibody drug as an alternative way to prevent viral transmission in high-risk locations. The post Lilly’s antibody for COVID-19 protection starts nursing home trial appeared first on. Results are due before the end of the year.

Nurses 57
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How well does vaccination work in residents of long-term care homes?

Scienmag

Researchers aim to find out Credit: Schlegel Villages, Ontario, Canada MONTREAL, MARCH 18, 2021 – Long-term care homes have been at the epicentre of the COVID-19 pandemic in Canada, with 70 percent of COVID-19 deaths having occurred in long-term care or nursing homes.

Nurses 93
article thumbnail

FDA Clears Second COVID Vaccine for Emergency Use

The Pharma Data

19, 2020 (Healthday News) — Moderna’s coronavirus vaccine was granted emergency use approval by the U.S. Food and Drug Administration on Friday, and it will now join Pfizer’s vaccine in an unprecedented national campaign to inoculate enough Americans to stem the spread of COVID-19. SATURDAY, Dec.

article thumbnail

Moderna’s FDA COVID-19 Vaccine Adcom is Thursday, and Expectations are High

The Pharma Data

ICU nurse Sandra Lindsay, with Long Island Jewish Medical Center in Queens, New York, received the Pfizer-BioNTech COVID-19 vaccine. Food and Drug Administration (FDA) ’ s Vaccines and Related Biological Products Advisory Committee on Thursday, December 17. government, though not funding Pfizer-BioNTech’s research, did buy $1.95

article thumbnail

FDA Says It Will Quickly Approve Moderna’s COVID Vaccine

The Pharma Data

Food and Drug Administration said Thursday night that it will move quickly to authorize the emergency use of Moderna’s coronavirus vaccine after one of its advisory panels voted to give its blessing to the shot. “Following today’s positive advisory committee meeting outcome regarding the Moderna COVID-19 vaccine, the U.S.

article thumbnail

As U.S. Decides Who Gets COVID Vaccine Next, More Infectious Strain Seen in Britain

The Pharma Data

experts announced Sunday which Americans will be next in line receive a COVID-19 vaccine, health officials worldwide worried about a new strain of coronavirus that appears to spread faster than before. The two latest groups in line for a vaccine number roughly 50 million. The new COVID-19 vaccines target that spiky protein.